Liver function tests analyze specific proteins and enzymes in the blood to evaluate how well the liver is working. These tests detect damage, inflammation, or impaired function, often before symptoms appear.
Commonly ordered during routine checkups or when jaundice, fatigue, or abdominal pain occurs, liver function tests include measurements of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), bilirubin, and albumin. Abnormal results may signal hepatitis, fatty liver disease, cirrhosis, or bile duct obstruction.
The American Association for the Study of Liver Diseases (AASLD) recommends baseline liver function testing for individuals with risk factors such as heavy alcohol use, obesity, or viral hepatitis exposure. Results are interpreted alongside clinical history and imaging, not in isolation.
Liver function tests assess five primary markers: ALT, AST, ALP, bilirubin, and albumin. Each reflects different aspects of liver activity and health.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are enzymes released into the bloodstream when liver cells are damaged. ALT is more specific to the liver; AST appears in the liver, heart, and muscles. A normal ALT level is typically below 40 U/L; AST below 35 U/L. Levels above these thresholds suggest hepatocellular injury.
Alkaline phosphatase (ALP) rises when bile flow is blocked. Elevated ALP often indicates cholestasis-impaired bile excretion due to gallstones, tumors, or primary biliary cholangitis. Normal ALP ranges from 40 to 129 U/L depending on age and sex.
Bilirubin is a byproduct of red blood cell breakdown processed by the liver. Total bilirubin normally stays under 1.2 mg/dL. Levels above 2.0 mg/dL indicate jaundice. Direct (conjugated) bilirubin above 0.3 mg/dL suggests liver cell dysfunction or biliary obstruction.
Albumin is a protein made by the liver. Low levels (below 3.5 g/dL) signal chronic liver disease or malnutrition. Albumin's half-life is about 20 days, making it a marker of long-term liver synthetic capacity.
| Test | Normal Range (US units) | What It Indicates |
|---|---|---|
| ALT | 7-56 U/L | Liver cell damage |
| AST | 10-40 U/L | Liver or muscle injury |
| ALP | 40-129 U/L | Bile flow obstruction |
| Total Bilirubin | 0.3-1.2 mg/dL | Jaundice, liver processing issues |
| Albumin | 3.5-5.0 g/dL | Chronic liver impairment |
Abnormal liver function tests don't diagnose a condition-they flag potential problems requiring further investigation. For example, isolated elevation in ALT with normal AST and ALP suggests non-alcoholic fatty liver disease (NAFLD), especially in patients with metabolic syndrome.
A pattern of high AST and ALT with elevated ALP and bilirubin points toward autoimmune hepatitis or primary sclerosing cholangitis. The ratio of AST to ALT matters: a ratio above 2:1 raises suspicion for alcoholic liver disease.
One study published in *Gastroenterology* found that 30% of patients with mildly elevated ALT had underlying NAFLD, even without symptoms. This underscores that subtle changes matter. A single abnormal result doesn't confirm disease-trends over time are critical.
Many assume that elevated liver enzymes always mean liver disease. That's incorrect. Medications, strenuous exercise, and even recent meals can temporarily raise ALT and AST. A 2021 review in *The Journal of Hepatology* noted that up to 15% of people with transient elevations return to normal within six months without intervention.
Another misconception is that all liver problems show up in standard panels. Some conditions, like Wilson's disease or hemochromatosis, require specialized tests beyond routine liver function tests. These involve copper levels, iron saturation, and genetic screening.
Also, low albumin can stem from kidney disease or malnutrition-not just liver failure. A patient with advanced heart failure may have low albumin due to fluid retention and poor perfusion, not hepatic insufficiency.
A 45-year-old man presented with fatigue and mild right upper quadrant discomfort. His initial blood work showed ALT at 110 U/L, AST at 85 U/L, ALP at 140 U/L, total bilirubin at 1.8 mg/dL, and albumin at 3.8 g/dL.
ALT and AST were elevated, indicating hepatocyte injury. ALP was mildly raised, suggesting possible cholestasis. Bilirubin was above normal but not severely elevated. Albumin remained in the normal range.
Further evaluation revealed a history of daily alcohol consumption and ultrasound showing fatty liver. He was diagnosed with alcoholic steatohepatitis. After stopping alcohol and starting lifestyle changes, his ALT dropped to 45 U/L and AST to 30 U/L in three months.
This case shows that liver function tests provide early warning signs. They don't confirm a diagnosis but guide next steps like imaging, viral serologies, or biopsy.
Testing is recommended for those with risk factors: heavy alcohol use, diabetes, obesity, family history of liver disease, or exposure to hepatitis B or C. Routine screening is not advised for everyone, per guidelines from the American Gastroenterological Association.
If results are abnormal, follow-up includes repeating the test in 4-6 weeks to see if levels persist. Imaging such as ultrasound or FibroScan may assess fat accumulation or fibrosis. In some cases, a liver biopsy is needed to confirm diagnosis.
Most people with mild elevations recover with lifestyle changes. Severe or progressive abnormalities require specialist care and targeted therapy.